Bin Huang
Direttore/Membro del Consiglio presso 3SBIO INC.
Patrimonio netto: 26 M $ in data 30/04/2024
Posizioni attive di Bin Huang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| 3SBIO INC. | Direttore/Membro del Consiglio | 01/01/2006 | - |
| Corporate Officer/Principal | 01/01/1993 | 20/06/2019 | |
Collected Mind Ltd.
 Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company. | Direttore/Membro del Consiglio | 01/08/2006 | - |
| Taizhou Huan Sheng Investment Management Co., Ltd. | Direttore/Membro del Consiglio | 01/11/2010 | - |
| Amministratore Delegato | 01/11/2010 | - | |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Direttore/Membro del Consiglio | 01/01/1993 | - |
| Corporate Officer/Principal | - | - | |
| Ufficiale delle Risorse Umane | 01/01/1993 | - |
Storia della carriera di Bin Huang
Precedenti posizioni note di Bin Huang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Cina | 3 |
| Canada | 2 |
| Isole Cayman | 2 |
Posizioni
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
Collected Mind Ltd.
Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company. | Finance |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
- Borsa valori
- Insiders
- Bin Huang
- Esperienza
